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Phage vB_SauP_phiAGO1.3 (phiAGO1.3) is a polyvalent Staphylococcus lytic podovirus
with a 17.6-kb genome (Gozdek et al., 2018). It can infect most of the Staphylococcus
aureus human isolates of dominant clonal complexes. We show that a major factor
contributing to the wide host range of phiAGO1.3 is a lack or sparcity of target sites
for certain restriction-modification systems of types I and II in its genome. Phage
phiAGO1.3 requires for adsorption β-O-GlcNAcylated cell wall teichoic acid, which is
also essential for the expression of methicillin resistance. Under certain conditions an
exposure of S. aureus to phiAGO1.3 can lead to the establishment of a mixed population
in which the bacteria and phages remain in equilibrium over multiple generations. This is
reminiscent of the so called phage carrier state enabling the co-existence of phage-
resistant and phage-sensitive cells supporting a continuous growth of the bacterial
and phage populations. The stable co-existence of bacteria and phage favors the
emergence of phage-resistant variants of the bacterium. All phiAGO1.3-resistant cells
isolated from the phage-carrier-state cultures contained a mutation inactivating the two-
component regulatory system ArlRS, essential for efficient expression of numerous
S. aureus virulence-associated traits. Moreover, the mutants were unaffected in their
susceptibility to infection with an unrelated, polyvalent S. aureus phage of the genus
Kayvirus. The ability of phiAGO1.3 to establish phage-carrier-state cultures did not
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preclude its antistaphylococcal activity in vivo in an S. aureus nematode infection model.
Taken together our results suggest that phiAGO1.3 could be suitable for the therapeutic
application in humans and animals, alone or in cocktails with Kayvirus phages. It might
be especially useful in the treatment of infections with the majority of methicillin-resistant
S. aureus strains.
Keywords: ArlRS, bacteriophage carrier state, bacteriophage host range, biofilm, Caenorhabditis elegans
infection model, phage therapy, restriction-modification systems, Staphylococcus Rosenblumvirus genus phage
INTRODUCTION
Staphylococcus aureus is among the most challenging bacterial
pathogens that cause various types of infections mainly in
humans but also in animals (Springer et al., 2009; Otto, 2012).
It has developed resistance to virtually all categories of antibiotic
available for clinical use, but only methicillin-resistant S. aureus
(MRSA) has reached epidemic proportions globally and has
become a major worldwide problem (Mandell et al., 2010). MRSA
strains are common both in nosocomial and in community
settings (Bal et al., 2016). The limitation of effective MRSA
treatment options with antibiotics often leads to the development
of chronic infections and is a cause of increased mortality,
longer hospital stays and higher health care costs as compared
to methicillin-sensitive S. aureus (MSSA) strains (Cosgrove et al.,
2003; de Kraker et al., 2011).
One of the alternative approaches to curing infections
with antibiotic-resistant S. aureus strains is the use of lytic
bacteriophages (Borysowski et al., 2011; Kaz´mierczak et al.,
2014). These are natural parasites of bacteria that can specifically
infect and kill their host but are harmless to eukaryotic cells.
Numerous cases of successful treatment of S. aureus infections
with bacteriophages in animals (Iwano et al., 2018; reviewed by
Barrera-Rivas et al., 2017) and in humans (d’Herelle, 1931a,b;
MacNeal and Frisbee, 1936a,b; Sauve, 1936; Mie˛dzybrodzki et al.,
2012; Fadlallah et al., 2015; Fish et al., 2016; reviewed by
Kaz´mierczak et al., 2014) have been described.
Several phages from the order Caudovirales, of a complex
virion structure comprising head and tail, are obligatorily lytic
on S. aureus hosts and cannot transfer bacterial DNA by
transduction. Thus, they can potentially be used in therapy
(reviewed by Łobocka et al., 2012). Most of them have a long,
contractile tail and have been currently classified to the family
Herelleviridae (Barylski et al., 2018). Some, less numerous and
including only 14 isolates of sequenced genomes have a short tail
(Vybiral et al., 2003; Kwan et al., 2005; Son et al., 2010; Kraushaar
et al., 2013; Swift and Nelson, 2014; Wang et al., 2016; Gozdek
et al., 2018). They belong to the Picovirinae subfamily of family
Podoviridae (Lavigne et al., 2008). Those that infect S. aureus
are much alike, despite being isolated in different geographical
regions (Kraushaar et al., 2013), and have been affiliated to the
Rosenblumvirus genus, subfamily Picovirinae (formerly 44AHJD-
like phages or 68-like phages) (Lavigne et al., 2008; Gozdek et al.,
2018).
The best known representative of Picovirinae is a model
Bacillus phage phi29. However, the similarities between phi29
and the staphylococcal Picovirinae are limited to a similar
genome size (17–20 kb) and tail morphology, partially conserved
synteny between the genomes and the presence of terminal DNA
repeats, protein-primed DNA replication and also structural
homologies between certain proteins (Vybiral et al., 2003;
Lavigne et al., 2008; Kraushaar et al., 2013). Functions of about
half of the proteins encoded by the staphylococcal phages
could be predicted based on their homology. The major head
protein, receptor binding protein (RBP) and two virion proteins
of unknown function were identified by proteomic studies
(Uchiyama et al., 2017; Štveráková et al., 2018).
The interactions of the staphylococcal Picovirinae phages with
their host cells are only beginning to be understood. Their
adsorption to the cell surface requires a specific glycosylation
pattern of the wall teichoic acid (WTA), which depends
on the activity of tarM- or tarS-encoded glycosyltransferases
catalyzing α-O-GlcNAcylation and β-O-GlcNAcylation of WTA,
respectively (Li et al., 2015). Studies on the adsorption
requirements of various Rosenblumvirus phages and the results
of phylogenetic analysis of their RBPs allowed distinguishing two
subgroups: phages that require β-O-GlcNAcylation of WTA for
adsorption (SAP-2, SLPW, S13′, SCH1, Psa3, GRCS, 44AHJD,
P68 and 66), and phages that adsorb to α-O-GlcNAcylated
as well as β-O-GlcNAcylated WTA (S24-1 and BP39) (Li
et al., 2015; Uchiyama et al., 2017). Consistent with the
adsorption-promoting TarS-mediated WTA modification and
adsorption-inhibiting TarM-mediated WTA modification some
phages of subgroup I have also been shown to infect strains
of Staphylococcus xylosus and Staphylococcus equorum, which
encode homologs of S. aureus TarS but lack genes encoding
homologs of TarM (Li et al., 2015). A phage tail lysin contributes
to the penetration of phage DNA into the host cell. Another
protein is associated with the DNA ends (Vybiral et al., 2003).
Based on the homologies between DNA polymerases and between
certain structural proteins of phi29 and Rosenblumvirus phages
the lytic development of the latter is assumed to be similar to that
of phi29, albeit it has not been studied. Cell lysis allowing phage
release depends on phage endolysin, whose gene is located within
a cluster of morphogenesis genes, unlike in phi29 (Lavigne et al.,
2008).
Studies on the antistaphylococcal activity of Rosenblumvirus
genus phages in vivo are sparce. One of these phages, S13’,
was demonstrated to have a life-prolonging effect on S. aureus-
infected silkworm larvae and protected about 40–50% of mice
infected with S. aureus from death, including the death from
lung-derived septicemia (Takemura-Uchiyama et al., 2013, 2014).
Endolysin of another phage, SAP-2, was active in decreasing
the biofilm mass of various S. aureus and S. epidermidis strains,
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as estimated in visual assay experiments (Son et al., 2010).
Its lytic activity against various strains was wider than that of
the parental phage. Little is known about the phage–bacteria
interactions leading to severe limitation of bacterial growth
without, however, threatening the phage with extinction due to
elimination of its host. To fill in this gap we characterized here an
additional phage of this genus, phiAGO1.3. We have identified its
properties contributing to the wide host-strain range, and show
its atypical strategy of co-existence with the host. Additionally,
we demonstrate that this strategy not only does not preclude the
antistaphylococcal activity of phiAGO1.3 in vivo but even leads
to the selection of bacterial mutants of attenuated virulence.
MATERIALS AND METHODS
Phage, Bacterial, and Nematode Strains
and Culture Conditions
Staphylococcus aureus podovirus vB_SauP_phiAGO1.3
(phiAGO1.3) used in this study was isolated earlier by us
from Warsaw sewage (Golec et al., 2011; Gozdek et al., 2018).
However, using primers specific for temperate phages of
various integrase types (Goerke et al., 2009) we identified
a prophage/phage of 855 integrase type in the bacterial
strain used for phiAGO1.3 propagation (2064/05), and in the
phiAGO1.3-derived lysates of this strain (data not shown). To
avoid contamination with this phage, strain 80wphwpl, which
had been cured of active prophages and plasmids and whose
genomic sequence had been determined (Łobocka et al., 2016)
was used for phiAGO1.3 propagation in the present study.
The monoclonality of the starting phiAGO1.3 preparations
obtained from 80wphwpl cells was confirmed by negative results
of PCR with a primer pair specific for the 2064/05-derived
prophage (data not shown). Another phage used in this study,
A5W, is a representative of Kayvirus genus and was described
previously (Łobocka et al., 2012). The list of Staphylococcus spp.
reference strains and S. aureus strains used in this study is given
in Supplementary Table 1 and Figure 1, respectively. Of 75
S. aureus strains used, 74 strains came from the MICROBANK
collection of the National Medicines Institute (NMI), Warsaw,
Poland. Sixty six of them comprised clinical strains isolated
from inpatients between 1999 and 2011. Eight of them were
from nasal colonization in human (n = 5), from environmental
samples (n = 2), and from bovine mastitis (n = 1). The isolates
were characterized, at the phenotypic and molecular level; they
represented 14 genetic lineages (MLST-Clonal Compexes [CCs]:
CC1, CC5, CC7, CC8, CC8/239, CC9, CC15, CC22, CC30, CC45,
CC59, CC97, CC121, and CC398). Thirty five isolates resistant
to methicillin (MRSA) were assigned to 27 MRSA clones.
They included hospital-, community- or livestock-associated
representatives of 10 CCs (CC1, CC5, CC7, CC8, CC8/239,
CC22, CC30, CC45, CC59, and CC398). Methicillin-susceptible
S. aureus (MSSA) isolates (n = 39) belonged to all CCs with
the exception of CC8/239. S. aureus strain RN4220 (CC8) is a
restriction-modification deficient and prophage-free derivative
of NCTC8325 described previously (Kreiswirth et al., 1983; Nair
et al., 2011). Bacteria were grown at 37◦C with constant shaking
(200 rpm) in Luria-Bertani broth (LB; Difco), in brain heart
infusion broth (BHI; Oxoid) or in trypticase soy broth (TSB;
Difco), as indicated.
A standard laboratory Caenorhabditis elegans strain Bristol N2
(wild-type) was used as a model host for S. aureus infection in all
experiments. It was obtained from the Caenorhabditis Genetics
Center (CGC), University of Minnesota. The nematodes were
maintained on NGM agar medium and fed E. coli strain OP50
as described elsewhere (Sulston and Hodgkin, 1988).
Phage Propagation
To ensure the lack of contamination of phiAGO1.3-containing
cell lysates with temperate phages or plasmid DNA the phage
that was originally obtained by propagation in S. aureus 2064/05
(Gozdek et al., 2018) was passaged several times from a single
plaque through S. aureus 80wphwpl, and lysates were verified
for the absence of 2064/05-derived phage DNA by PCR with
2064/05-prophage (integrase type 855) specific primer pair
(Goerke et al., 2009). Only confirmed monoclonal lysates were
used for phiAGO1.3 propagation on a larger scale in 80wphwpl
cells.
Phage Purification
Cell lysate containing phages (50 ml, 1011 PFU/ml) was filtered
through 0.22-µm pore size membrane (MILLEX R© GS) and
treated with RNase A (PureLink RNase, Invitrogen) and DNase
(Turbo DNase, Ambion) (final concentration 20 µg/ml of each)
at 37◦C for 2 h. Next, the lysate was supplemented with
polyethylene glycol (PEG6000) and NaCl to final concentrations
of 10% and 1 M, respectively, and incubated on ice for 24 h.
Samples were centrifuged (10,000 × g, 30 min, 4◦C) and the
pellet was resuspended in phosphate buffered saline (PBS: 10 mM
Na2HPO4, 137 mM NaCl, 2.7 mM KCl, 2 mM KH2PO4 at
pH 7.4).
Determination of Bacteriophage Host
Range With a Spot Test
Overnight cultures of various S. aureus strains in LB medium
(0.2 ml) were supplemented with CaCl2 and MgSO4 to the final
concentration of 2.5 mM each, mixed with 1 ml LB and 8 ml
molten LCA (55◦C), overlaid on LB agar medium in Petri dishes,
and left to solidify. Lysates containing phages were standardized
by diluting in LB to obtain the titer of 108, 106, and 104 PFU/ml.
Ten microliters of each lysate at each dilution was spotted on the
cell layer of each strain. Plates were incubated overnight at 37◦C,
and the number and morphology of plaques were determined.
Assays of Bacteriophage Lytic Activity in
Liquid Cultures of S. aureus
Overnight cultures of various S. aureus strains were diluted
1:100 in fresh LB medium supplemented with CaCl2 and MgSO4
(2.5 mM each). Aliquots of each culture (190 µl) were added to
wells of sterilized honeycomb plates and incubated in a Bioscreen
C Microbiology Plate Reader (Growth Curves USA, Piscataway
Township, NJ, United States) at 37◦C until the optical density
(OD600) reached ca. 0.2. The cultures were then supplemented
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with the phage at MOI of about 0.1 and 1 by the addition of 10 µl
of an appropriately diluted lysate or LB (control samples). The
cultures were left for 10 min at room temperature (RT) without
shaking to allow for phage adsorption, and then were incubated as
above with medium intensity shaking for 24 h. The optical density
of the cultures was measured during the whole experiment in
15-min intervals.
Assay of Bacteriophage Influence on
Preformed S. aureus Biofilms
The ability of phiAGO1.3 to disrupt preformed S. aureus biofilm
was assayed as described previously (Stepanovic et al., 2000),
with some modifications. S. aureus scraped from fresh LB agar
plate was inoculated in 1 ml of BHI containing 2% sucrose,
incubated overnight at 37◦C without shaking and diluted 1:100
in fresh medium. Aliquots of bacterial suspension (100 µl) were
transferred to wells of sterile 96-well flat-bottom polystyrene
plates (Greiner Bio-One, Germany) containing a preformed
fibrinogen layer (50 µg fibrinogen in 100 µl of water per well,
incubated for 24 h at 4◦C and carefully aspirated). Bacterial
biofilm was allowed to form for 24 h at 37◦C without agitation.
The wells were then carefully washed twice with 200 µl of
phosphate buffered saline (PBS). Next, 100 µl of diluted bacterial
lysate containing phage (108 PFU/ml) or LB (control) was added,
the plates were incubated for 24 h as above and washed twice
with PBS. The biofilm was fixed with 200 µl of 99% methanol
for 15 min, drained, left to dry at 50◦C for 1 h, and then stained
with 0.01% crystal violet (CV; 200 µl) for 15 min. Excess CV was
removed by washing three times with water and the wells were
air-dried. The amount of CV bound by the biofilm was quantified
by solubilizing in 200 µl of 33% acetic acid for 10 min followed
by determination of the optical density of the obtained solution
at 570 nm using a microplate reader (Bio-tek SynergyTM HT).
Killing Assay
The fraction of bacteria surviving phage infection was
determined by killing assay, as described previously (Carlson,
2004; Abedon, 2017), with some modifications. Briefly, 80wphwpl
culture (10 ml, OD600 of about 0.4) was infected with phiAGO1.3
at MOI 1 and 10 and left for 15 min at RT to allow for phage
adsorption. The same volume of uninfected culture was used as a
control. Samples were placed on ice, immediately serially diluted
10-fold in cold LB and spread on LB agar plates. The plates were
incubated at 37◦C for 24 h and bacterial colonies formed were
counted. The fraction of surviving cells was calculated based on
the ratio between the number of colonies formed by cells from
infected and uninfected cultures.
Identification of Phage-Releasing
Colonies
Single S. aureus colonies recovered following phage infection
described as above, were transferred onto a top agar overlay
of strain 80wphwpl, incubated overnight at 37◦C and checked
for the presence of a lysis zone – a hallmark of spontaneous
phage release. The presence of phiAGO1.3 was additionally
verified by PCR with phage-specific primers. Briefly, candidate
colonies were suspended in 100 µl of ice-cold water, and
1 µl of the suspension was used as a source of template
for the DNA amplification with primers OMLO707 5′-
TGCATGGCTTGTTTTGCTAAAGC-3′ and OMLO708
5′-ACAAGCWGGACAACCGTCTTGGT-3′. PCR conditions
were as follows: 95◦C for 15 min (95◦C for 30 s, 55◦C for 30 s,
75◦C for 1 min)× 30, 75◦C for 7 min.
Determination of Phage Carrier State
Stability
To evaluate the stability of the phage carrier state the fraction
of cells retaining phiAGO1.3 following consecutive cell divisions
was determined. Briefly, phage-releasing colony (designated
as FTpt further in this manuscript) identified as above was
suspended in 100 µl of cold water, placed on ice, immediately
serially diluted 10-fold in cold LB and spread on LB agar plates.
The plates were incubated at 37◦C for 24 h, and colonies formed
(designated as first generation: G1) were transferred onto a top
agar overlay of strain 80wphwpl. After overnight incubation
at 37◦C, the percentage of phage-producing colonies (FTpt) in
G1 population was determined. The procedure was repeated
six times starting each time from cells of one phage-producing
colony.
Evaluation of phiAGO1.3 Efficacy in
Curing S. aureus-Infected Nematodes
The ability of phiAGO1.3 to cure nematodes infected with
S. aureus 80wphwpl was assayed as previously described
(Łobocka et al., 2014b), with some modifications. An overnight
tryptic soy broth (TSB) bacterial culture was diluted 1:100 in fresh
medium and 100 µl was spread on a 5.5-cm diameter tryptic soy
agar (TSA) plate and incubated at 37◦C for 24 h. C. elegans larvae
at T4 stage taken from a synchronized culture were transferred
to a lawn of S. aureus cells and incubated at 25◦C for 24 h. The
infected nematodes were then rinsed from the plates, placed on
a nylon mesh (CellMicroSieves, BioDesign) with 10-µm pores,
washed twice with 5 ml of LB medium, and transferred onto a
TSA plate. Then, they were covered with 5 ml of phage lysate
(109 PFU/ml) or LB medium (control), and incubated at RT for
1 h. The nematodes were then washed on a nylon mesh as above,
transferred onto a TSA plate and left to dry. Twenty worms were
picked randomly using a platinum wire pick and transferred to a
fresh TSA plate. The plates were incubated at 25◦C and scored for
live and dead worms in 24-h intervals.
Isolation of S. aureus DNA
Bacteria were harvested from overnight cultures (3 ml) by
centrifugation (10,000 × g for 10 min) and resuspended in
200 µl of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH
8.0). Lysostaphine (Sigma) and RNase (Invitrogen) was added
to 200 and 10 µg/ml, respectively, the sample was shaked
vigorously and incubated at 37◦C until the culture lysed. DNA
was extracted using the EXTRACTME kit for genomic DNA
isolation from bacteria (Blirt DNA-Gdan´sk, Poland), according
to manufacturer’s guidelines. DNA quality and quantity was
checked by agarose gel electrophoresis.
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S. aureus Genomic DNA Sequencing,
and Sequence Assembly and Analysis
Staphylococcus aureus genomic DNA was sheared mechanically
to ∼600–700 bp and used for Paired-End TruSeq-like
library construction using a KAPA Library preparation kit
(KAPA/Roche, Basel, Switzerland) following manufacturer’s
instructions. The library was sequenced in the paired-end mode
(v3, 600 cycle chemistry kit) on a MiSeq instrument (Illumina,
San Diego, CA, United States). Sequence reads were filtered
by quality using the ultra-fast FASTQ preprocessing toolkit,
fastp version 0.14.1 (Chen et al., 20181). As an additional stage,
performed only for the clone of control 80wphwpl strain used
in this study (designated as 80wphwpl_v1), long reads were
generated to aid genome assembly using a MinION nanopore
sequencing instrument (Oxford Nanopore Technologies,
Oxford, United Kingdom). Approximately 1 µg of unsheared
DNA was used for library preparation using the ONT Rapid
Barcoding sequencing kit (SQK-RBK004). Nanopore sequencing
was performed using the NC_48h_Sequencing_Run_FLO-
MIN106_SQK-RBK004 protocol (MinKnow version 2.2) and
R9.4.1 MinION flowcell. Raw nanopore data was basecalled
using Albacore v2.3.1 (Oxford Nanopore Technologies, Oxford,
United Kingdom). Following quality filtering and sequencing
adapter removal using Porechop2 17,527 barcoded reads
remained. The median read length of the obtained dataset
(132,564,821 of bases in total) was 5,649 bases. Long nanopore
reads were assembled in a hybrid mode with the Illumina data
using Unicycler v.0.4.6 (Wick et al., 2017). Genome hybrid
assembly resulted in a single circular replicon. The suspected
errors in the genome assembly, especially in genes containing
tandem repeats, were verified by PCR amplification of relevant
DNA fragments followed by Sanger sequencing on an ABI3730xl
Genetic Analyzer (Life Technologies, United States) using
BigDye Terminator Mix v. 3.1 chemistry (Life Technologies,
United States). Missassemblies were further corrected using
Seqman software (DNAStar, United States) to obtain the
complete nucleotide sequence of 80wphwpl_v1 (2,732,618 bp).
This newly generated consensus sequence of the parent strain
genome was used as a template for the genomic sequence
assembly of the S. aureus isolates resistant to infection with
phiAGO1.3. Desktop software Geneious 11.0.4 (Biomatters,
Ltd., Auckland, New Zealand) was used for the assembly. The
alignments obtained served for the detection of differences
between the mutants and the parental strain. Additional
inspection of the sequence reads in the alignments served
to exclude the ambiguities in the consensus sequence of the
reference and mutant strains in the regions of detected mutations.
RESULTS
Basic Characteristics of phiAGO1.3
Bacteriophage phAGO1.3 was originally isolated from sewage as
an obligatorily lytic phage capable of infecting most S. aureus
1http://dx.doi.org/10.1101/274100
2https://github.com/rrwick/Porechop
strains from a small collection of clinical isolates (Gozdek et al.,
2018).
Measurement of typical phage growth parameters revealed
that phiAGO1.3 could be a potential candidate for therapeutic
applications. It can adsorb quickly to its host cells and has a short
latent period (∼30 min) (Supplementary Figure 1). Its burst size
was estimated to be about 35. Additionally, its titer in the lysate
did not change significantly after 1 h of incubation at 37 or 50◦C
or at pH from 5 to 9 (Supplementary Figure 2). Only incubation
at temperatures of 60◦C or higher or at pH below four or above
10 caused a drastic decrease of the phage activity. The optimal
MOI for phiAGO1.3 propagation in S. aureus 80wphwpl was
determined to be 0.01 (data not shown).
Coding Potential of phiAGO1.3 and
Analysis of Its Structural Proteome
The genome of phiAGO1.3 encodes 20 proteins (Gozdek et al.,
2018). Their homologs are found in various Picovirinae that
infect S. aureus. Phages GRCS and PSa3, which, respectively,
encode eight and seven of them, appear to be the closest relatives
of phiAGO1.3 at the protein sequence level (Supplementary
Table 2). Close homologs of all phiAGO1.3 proteins are also
encoded by prototypical Rosenblumvirus phages 44AHJD or 68.
Eleven of the phiAGO1.3 proteins are virion components, as
identified by a mass spectrometry analysis of tryptic peptides
of whole virions (Supplementary Table 3). Homologs of nine
of them, including the major capsid protein, two tail proteins,
lower and upper collar protein, RBP and tail amidase, have been
identified or predicted previously as virion proteins of related
phages (Vybiral et al., 2003; Takemura-Uchiyama et al., 2013;
Uchiyama et al., 2014; Štveráková et al., 2018). The two additional
virion proteins of phiAGO1.3 identified in this work (ORF01 and
ORF07) are present in virions in a small amount as suggested
by the small number of their peptides in analyzed samples
(Supplementary Table 3). They have counterparts in related
staphylococcal phages, but do not have apparent homologies
to proteins of known function. One of them could act as the
terminal protein priming the phage DNA replication, by analogy
to phi29. DNA termini of phage 68, closely related to phiAGO1.3,
have been shown to be covalently bound to a protein (Vybiral
et al., 2003). A virion protein of phiAGO1.3 that might somehow
contribute to the host specificity is ORF20. It appears to be,
besides the tail fiber protein (ORF13), the most variable part of
S. aureus Rosenblumvirus phages’ virions. It is a highly acidic
protein, which in phiAGO1.3 contains six repeats of ES/LTE
amino acid sequence motif. The variability of ORF20 and its
homologs in S. aureus phages results partly from the differences
in the number of these repeats.
Determination of phiAGO1.3 Lytic
Spectrum
Certain polyvalent staphylococcal phages infect representatives of
various Staphylococcus sp. Thus, we tested the sensitivity of 12
selected type strains of Staphylococcus spp. other than S. aureus
to phiAGO1.3 (Supplementary Table 1). The phage infected
productively one of the two tested strains of Staphylococcus
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hyicus, which like S. aureus belongs to coagulase-positive
staphylococci, and, surprisingly, a type strain of a coagulase-
negative Staphylococcus–Staphylococcus lugdunensis (DSM No.
4804, data not shown).
To evaluate the potential of phiAGO1.3 to control S. aureus
we tested its lytic activity against agar-embedded cells, planctonic
cells and biofilms of 75 S. aureus clinical isolates from a diversified
collection (Figure 1). The phage infected productively 55 (73%)
of those strains when tested by a spot test, as indicated by
the formation of a lysis zone at high phage doses (107–105
PFU/10 µl), and single plaques or confluent plaques with some
borders between them visible at lower phage doses. In the assays
of the phage lytic activity in liquid culture a significant decrease
of the culture density was observed for 61 (81%) of strains upon
addition of phiAGO1.3 (Figure 1 and Supplementary Figure 3).
This difference in the number of susceptible strains is likely
caused by the low efficiency of infection of some of them (e.g.,
10250/11) resulting from the action of their restriction systems.
Conceivably, the initial infection required some population
phages to break the restriction barrier of the infected strain.
This in turn could lead to the lytic development of the phage
and the release of appropriately modified progeny phages able to
infect cells of this strain efficiently. Such effect of a lack of strain-
specific DNA modifications in the phage DNA has been observed
previously for other staphylococcal obligatorily lytic phages (see,
e.g., Pantu˚cˇek et al., 1998).
The pattern of the culture density changes upon addition of
phiAGO1.3 differed for different S. aureus strains. In the case
of 44 strains all or nearly all cells in the culture underwent lysis
(Supplementary Figure 3A). For the remaining 17 strains the
drop in culture density, even at MOI 1, was small and followed by
a plateau (Supplementary Figure 3B) suggesting that productive
infection of some cells may be accompanied by the continuous
growth of uninfected or resistant cells.
Fourteen of 75 strains tested did not lyse in liquid cultures
upon addition of phiAGO1.3 (Figure 1 and Supplementary
Figure 3C). Additionally, we could not obtain single plaques in
the spot test with those strains at any phage dose, despite the
presence of lysis zones at high phage doses. Notably, for the latter
strains similar lysis zones were obtained using suspensions of
purified phage, indicating that they are not caused by free lysins
or bacteriocins but by the phage itself. The observed effect could
be caused by so called “lysis from without” or by the activity of
bacterial phage defense systems causing death of infected cells
to stop the phage spread. Apparently, phiAGO1.3 can adsorb to
cells of those strains and penetrate their cell envelopes, but the
infection is not productive.
Only three S. aureus strains of the entire set tested (RN4220,
3812/16, and 3793/16) appeared to be insensitive to phiAGO1.3
as indicated by the lack of any lysis in the spot tests and in liquid
culture treated with the phage. Conceivably, their resistance is
due to a lack of appropriate phage receptors.
In the majority of cases S. aureus forms biofilms at the site
of infection (Moormeier and Bayles, 2017). Thus, we determined
the effect of phiAGO1.3 on the biofilm mass of the strains tested
(Table 1 and Supplementary Figure 4). In the case of the strains
which could not be infected productively in the former assays,
phage addition to the preformed biofilm did not influence the
biofilm biomass or caused an increase (from 21% to as much
as 108%) or a slight decrease of the biofilm biomass. For all
the strains that were productively infected with phiAGO1.3, a
significant decrease of biofilm biomass (mostly by over 80%) was
observed (see Figure 1 and Supplementary Figure 4).
Properties of phiAGO1.3 Contributing to
Its Wide S. aureus Strain Range
Staphylococcus aureus protection from invading foreign DNA
and from horizontal gene transfer between different lineages
is provided mainly by Type I DNA restriction-modification
(R-M) systems, which were generally designated as Sau1
although their methylation specificity varies between different
CCs (Waldron and Lindsay, 2006). The ability of phiAGO1.3 to
infect productively strains of at least 12 CCs implies that either it
lacks the relevant target sequences in its DNA or encodes a potent
antirestriction system. The target sequences of certain S. aureus
R-M systems have been identified (McCarthy and Lindsay, 2010,
2012; McCarthy et al., 2012; Roberts et al., 2013; Monk et al., 2015;
Chen et al., 2016; Cooper et al., 2017). The phiAGO1.3 genome
carries no recognition sequences for CC1-2, CC8, CC30, CC45,
CC51, CC72-2, CC75-2, CC93-3, CC97 and CC133-2 Sau1 R-M
systems, and only single recognition sequences for CC1-1, CC59,
CC72-1, CC93-2, and CC133-1 Sau1 R-M systems (Table 1). The
DNA cleavage by restriction endonucleases of classical Type I
R-M systems requires a collision of two enzymes translocating
toward each other (Studier and Bandyopadhyay, 1988; Dreier
et al., 1996; Jindrova et al., 2005; Šišáková et al., 2013). Thus,
a single site does not suffice for the digestion of infecting
linear phage DNA. In addition to Type I R-M systems several
S. aureus strains encode Type II R-M systems such as Sau3A,
Sau96I, and isoschizomers of SmlI that recognize 5′-GATC, 5′-
GGNCC, and 5′-CTYRAG sequences, respectively, and cleave
them if they are not methylated (Sussenbach et al., 1976, 1978;
Stobberingh et al., 1977; Szilák et al., 1990; Godány et al., 2004).
The genome of phiAGO1.3 contains only two GATC sequences
and no GGNCC sequences. Taken together these results indicate
that the elimination of certain restriction enzyme recognition
sites is the dominant phiAGO1.3 strategy to avoid the activity of
host R-M systems.
Killing Efficacy of Its Bacterial Host by
phiAGO1.3 and the Establishment of
Phage Carrier State
The efficacy of a given phage to kill the infected bacteria, so
called killing efficacy, is a critical parameter in the evaluation
of phage therapeutic potential (Carlson, 2004; Łobocka et al.,
2014a; Abedon, 2017). The killing efficacy reflects a sum of the
bacteria killed as a result of productive phage propagation and
those killed without the productive propagation, e.g., by the
induction of bacterial apoptosis. Infection of S. aureus 80wphwpl
with phiAGO1.3 at MOI 1 caused killing of about 74% of cells,
whereas the infection at MOI 10 caused killing of 93% of cells.
Irrespective of the MOI used for the infection, the bacteria
that survived the infection formed colonies of two morphological
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TABLE 1 | Number of target sites for the Staphylococcus aureus R-M systems of Type I and Type II of known specificities in phiAGO1.3 genome.
Clonal complex HsdS subunit name in
REBASE
Generic name Recognition sequence Number of
targets in
phiAGO1.3
DNA
I/T∗
CC1 S. SauMW2I
S. SauMW2II
CC1-1
CC1-2 (CC8-2)
CCAY-5-TTAA
CCAY-6-TGT
1
0
4/5
CC5 S.SauN315II
S.SauN315I
CC5-2
CC5-1 (CC8-2)
CCAY-6-GTA
AGG-5-GAT
3
0
10/10
CC8# 0 7/8
CC15 S.SauL3150RFAP CC15-1 CAAC-5-RTGA 0 4/5
CC22 S.Sau5096I CC22-1 AGG-6-TGAR 5 4/4
CC30 S.SauMRSII
S.SauMRSI
CC30-1
CC30-2
GWAG-5-GAT
GGA-7-TCG
0
0
8/8
CC45 S.Sau347I CC45-1 GWAG-6-TAAA 0 9/9
CC51 S.SauL30RFAP CC51-1 GGA-6-CCT 0 NT
CC59 S.SauSA40ORF370P CC59-1 GGA-6-RTGT 1 1/4
CC72 S.SauCN10RF415P
S.SauCN10RF1757P
CC72-1
CC72-2
GARA-6-RTGT
GGA-7-TGC
1
0
NT
CC75 S.Saull32ORF3780P
S.Saull32ORF16570P
CC75-1
CC75-2
CAAG-5-RTC
CNGA-7-TTYG
2
0
NT
CC93 S.SauJKDIII
S.SauJKDII
S.SauJKDI
CC93-3
CC93-2
CC93-1
GAAG-5-TAC
or complement
GGHA-7-TCG
CAG-6-TTC
0
3
1
3
NT
CC97 S.SauC01791ORFAP CC97-1 CCAY-6-RTC 0 0/1
CC133 S.Saul330RF451P
S.Saul330RF1794P
CC133-1
CC133-2
CAG-5-RTGA
GGA-7-TTRG
1
0
NT
CC398 S.SauSTORF499PCC398-l CC398-1 ACC-5-RTGA 5 3/4
CC873 S.Sau323260RFAP CC873-1 GAG-6-GAT 5 NT
Sau3A
Sau96I
R-M Type II enzymes GATC
GGNCC
2
0
∗ I/T indicates the number of infected strains as compared to the number of tested strains. # indicates that the sequences are the same as CC8-2.
types: those resembling colonies of non-infected cells (designated
here as WTpt, wild-type colonies after phage treatment) and
small, transparent colonies (designated as FTpt, frail type
colonies after phage treatment) (Figure 2A). The fraction of the
latter varied from 20 to 40%. While the transfer of cells from the
WTpt colonies to a layer of 80wphwpl cells embedded in soft
agar did not cause any effect, the transfer of cells from the FTpt
colonies caused the formation of lysis zones of indicator bacteria
(Figure 2B). The lysis was observed even after the FTpt cells were
washed several times before plating. Colony PCR of FTpt bacteria
with primers specific for phiAGO1.3 revealed the expected 353-
bp product, indicative of the presence of phiAGO1.3 (Figure 2C).
No product was obtained with WTpt colonies. Clearly, the
phenotype of FTpt colonies is associated with the presence of
phiAGO1.3 phage or phiAGO1.3 DNA.
The Establishment of Equilibrium
Between Host Bacteria and phiAGO1.3 in
Liquid Cultures
The optical density of 80wphwpl cultures infected with
phiAGO1.3 (107 PFU/ml) began to decrease after 7 h and
reached the lowest value (OD600 of about 0.2) at 15 h, and then
increased to reach a plateau (OD600 of about 0.9) at about 25 h
(Figure 3). The pattern of density changes in the culture of
cells derived from WTpt colonies and infected with phiAGO1.3
was similar, consistent with the sensitivity of these cells to
phiAGO1.3 (Figure 3Bd). In contrast, cultures derived from
FTpt colonies behaved differently. In the absence of externally
added phiAGO1.3 they grew poorly for the first few hours, then
increased the optical density for the next 6 h up to OD600 ca.
1.2 and then decreased the optical density to reach a plateau
(OD600 of about 0.6) at about 26 h (Figure 3A, empty circles).
A similar pattern of density changes was observed in the FTpt-
derived cultures when phiAGO1.3 (107 PFU/ml) was added to
the cultures at the beginning of the experiment. This lack of an
effect of external phage suggested that either the bacteria in the
culture were not accessible to the newly added phages or that
the infection by the newly added phages was prevented by other
means (Figure 3A, black circles). Cells of FTpt-derived cultures
taken at the 19-th hour, when a significant decrease of culture
density was observed (OD600 of about 0.9), formed colonies
of WTpt and FTpt types, at ratios varying between apparently
identical experiment repetitions (1:1, 2:1, 1:2) despite similar
curves of culture optical density changes. The total number of
cells in the culture at that time, as calculated from the sum of
WTpt and FTpt colonies formed, was 108 CFU/ml, while the total
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FIGURE 2 | Differentiation of colonies formed by phiAGO1.3-infected cells of S. aureus 80wphwpl. (A) Different colony morphotypes recovered following phiAGO1.3
infection: wild-type colonies, designated as WTpt (white arrow) and small, transparent colonies designated as FTpt (black arrow). (B) Identification of phage-releasing
colonies. Single S. aureus colonies recovered following phage infection were picked onto a layer of 80wphwpl cells in top soft LB agar, incubated overnight at 37◦C,
and checked for the presence of a lysis zone (WTpt, white arrow; FTpt, black arrow). (C) Presence of phiAGO1.3 in colonies surviving phage infection. PCR with
phage-specific primers was used to identify phage DNA. Lanes represent: (1) 1-Kb Plus DNA Ladder (Invitrogen), (2) PCR with no template, (3 and 4) Colony PCR
with WTpt and FTpt colonies as a source of template, respectively, (5) PCR with phiAGO1.3 as template. White arrowheads indicate 400- and 300-bp marker.
number of phages, as calculated by titration, was 109 PFU/ml. In
a sample taken at the 32-nd hour the total number of cells was
107 CFU/ml and of phages – 109 PFU/ml. Apparently, the phage
and the bacteria can reach a kind of equilibrium in which they
can stably coexist with each other.
We reasoned that the FTpt colonies could not increase in
size and could not give rise to a growing liquid culture if they
did not contain at least a fraction of cells able to grow and
divide. Thus, we tested what kind of cells contribute to the
formation of FTpt colonies. Single FTpt colonies (designated
as G0 generation) were used as the starting material in these
experiments. To decrease the probability of phage release and
infection of new cells during cell handling and to slow down cell
division, suspensions of cells of single FTpt colonies and dilutions
were prepared in ice-cold water and the cells were immediately
spread on LB plates (the whole procedure did not exceed 3 min).
The FTpt progeny cells formed colonies of both the FTpt and
WTpt types. To test whether and to what extent the segregation
phenotype is inheritable the whole procedure of cell washing,
dilutions and plating was repeated with each next passage of cells
of FTpt colonies up to seven rounds. Regardless of the passage
the fraction of cells forming FTpt colonies varied between 40 and
90% and did not show any tendency to decrease with subsequent
passages. Colonies from all the passages studied were tested for
the ability to release phiAGO1.3 by their application on a layer
of 80wphwpl cells in soft LCA. All FTpt colonies released the
phage, while no WTpt colonies did. Taken together our results
demonstrate that FTpt colonies are a mixture of two types of
bacterial cells and that the phage carrier state is inheritable. The
recurrent segregation of FTpt colonies into phage-releasing cells
and phage-free cells sensitive to phage infection ensures a stable
co-existence of bacteriophage and its host bacteria.
Isolation of Cells Resistant to Infection
With phiAGO1.3
When cells of FTpt colonies were suspended in molten LCA
medium and poured onto solid LB medium, as is commonly
done in the double-layer-agar assay of bacteriophage activity,
they formed a lysis zone. However, throughout the lysis zone
one could observe single bacterial colonies of various sizes
(Figure 4A), similarly as in the case of the lysis zones obtained
during phiAGO1.3 titration on a layer of 80wphwpl cells with the
use of high-titer lysates.
To test whether these colonies release the phage like the FTpt
colonies did, cells from the top of the colonies were transferred
on a layer of 80wphwpl cells embedded in soft agar. Similarly,
like as for the FTpt colonies, lysis zones of the indicator cells were
formed around the cells of tested colonies. However, opposite to
the test with the FTpt colonies, the intensive growth of bacteria
was observed in the center of the lysis zones (compare Figures 2B
and 4B). To distinguish these cells from cells of the parental FTpt
colonies they were designated RevFT (reverse colonies of FTpt).
All or some WTpt or RevFT cells could potentially represent
phage resistant clones. To verify this possibility they were tested
for the sensitivity to infection with phiAGO1.3. Cells from WTpt
turned out to be sensitive to phiAGO1.3, as indicated by the
ability of phiAGO1.3 to form lysis zones on a layer of these
cells in LCA (compare Figures 3Bd and 3Bb) and by the optical
density drop of their cell cultures upon addition of phiAGO1.3
(Figure 3A). Most likely, WTpt represent the progeny of cells
that avoided the encounter with phiAGO1.3, as happens in
killing assay experiments (Łobocka et al., 2014a). The results
were different for the RevFT colony-derived cells, as they did
not lyse upon phiAGO1.3 application (Figure 5Ba). Clearly,
RevFT are cells that have acquired resistance to phiAGO1.3
(Figure 5).
To check whether the resistance phenotype is stable, RevFT
cells were purified by passaging through fresh medium, re-
isolated from single colonies and tested for sensitivity to
phiAGO1.3 by spotting diluted cell suspension on a layer of
LCA soft agar containing phiAGO1.3 (109 PFU/ml). The RevFT-
derived cells formed colonies and their number was comparable
to that formed by a phiAGO1.3 resistant strain, RN4220 (data
not shown). Clearly, the resistance of RevFT cells to phiAGO1.3
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FIGURE 3 | Properties of S. aureus 80wphwpl (WT) and its derivatives recovered from phiAGO1.3-treated cultures (WTpt and FTpt). (A) Optical density changes of
liquid cell cultures of WT (empty triangles), WTpt (empty squares) and FTpt (empty circles) colonies grown without phiAGO1.3 added and upon addition of
phiAGO1.3 (filled triangles, squares, and circles, respectively). Portions of LB medium (190 µl) in duplicate were inoculated with appropriate colonies to OD600 of
about 0.1–0.2. One culture of each pair was supplemented with 10 µl of phiAGO1.3 suspension in LB (109 PFU/ml) and one (control) with 10 µl LB. Cultures were
grown in Bioscreen C at 37◦C with shaking. (Ba-f) Sensitivity of WT and WTpt- and FTpt-derived S. aureus to phiAGO1.3, as measured by a spot test. FTpt-derived
cells lysed spontaneously in the top agar (Be) and thus the site of phiAGO1.3 application in Bf is not visible.
is maintained even when their contact with the phage is
interrupted.
Certain phages of the genus Rosenblumvirus require WTA
for adsorption, similarly to the Kayvirus genus phages. However,
the RevFT cells, despite being resistant to phiAGO1.3 remained
sensitive to infection with the Kayvirus phage A5W, as indicated
by the assays in solid as well as in liquid medium (Figures 5A
[black squares] and 5Bb). Clearly, their resistance is not
associated with a change of any surface or internal cell structure
of S. aureus that could be essential for the sensitivity to A5W.
Identification of RevFT Mutation
Associated With the Resistance to
phiAGO1.3
The stable inheritance of phiAGO1.3 resistance by the progeny
of cells forming FTpt colonies prompted us to determine the
genomic sequence of several RevFT clones and compare it with
the sequence of the parental 80wphwpl strain (80wphwpl_v1
control clone). All nine RevFT isolates sequenced had the
substitution of G by T at position 1252 of the arl gene.
This substitution is a nonsense mutation changing a glycine
codon (GGA) to a STOP codon (TGA), which results in the
production of the ArlS protein depleted of 34 C-terminal amino
acid residues. ArlS is a sensory histidine kinase of the two
component S. aureus regulatory system ArlRS (Fournier and
Hooper, 20003). The premature termination of translation in
the mutant occurs exactly prior to the conserved GLGL motif
which is an essential part of the dimerization and phospho-
acceptor domain of ArlS protein (pfam HATPase_c domain) –
one of the essential units of the two-component transduction
system (Fournier and Hooper, 2000; West and Stock, 2001).
Consistently, the ArlRS system cannot be functional in the
mutant.
3http://www.ncbi.nlm.nih.gov/Complete_Genomes/SignalCensus.html
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FIGURE 4 | Emergence of phiAGO1.3-resistant clones among bacteria derived from FTpt colonies. (A) Growth of single FTpt-derived colonies on a layer of lysed
FTpt-derived cells in soft agar. Single FTpt colony was suspended in LCA and spread on LB agar. Plates were incubated for 24 h at 37◦C. Colonies formed were
designated RevFT. (B) Identification of phiAGO1.3-releasing isolates among RevFT-derived bacteria.
FIGURE 5 | (A) Sensitivity of RevFT-derived bacteria to two unrelated phages, phiAGO1.3 and A5W of Kayvirus genus. Optical density changes of RevFT culture
cells (white circles) upon addition of phage phiAGO1.3 (black squares) or phage A5W (white squares). (Ba,b) Sensitivity of RevFT cells to phiAGO1.3 and A5W, as
measured by a spot test.
Therapeutic Potential of phiAGO1.3 to
Cure Nematode Infection With S. aureus
80wphwpl
If an equilibrium between a phage and its host bacteria similar
to that observed in liquid cultures could be also established in
S. aureus-infected humans or animals during phage therapy it
might preclude the use of phiAGO1.3 for therapeutic purposes.
Thus, we tested whether phiAGO1.3 can rescue from death
C. elegans infected with S. aureus 80wphwpl. Figure 6 show that
80wphwpl is pathogenic to C. elegans, causing gradual death of
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FIGURE 6 | Antistaphylococcal activity of phiAGO1.3 in vivo. Percentage of
surviving worms fed S. aureus 80wphwpl (untreated control, white diamonds)
and treated with phiAGO1.3 (black diamonds). Each value is the mean of six
samples from three experiments where the total number of worms was 120.
The differences between experiments did not exceed 4% for untreated worms
and 1% for phiAGO1.3-treated ones.
more and more nematodes each day so that only about 20%
of them survived at 120 h post-infection. Additionally, none
of them produced progeny. Opposite to that over 80% of the
nematodes survived when they were treated with just one dose
of phiAGO1.3 (109 PFU/ml) 24 h after the infection. Moreover,
ca. 100 h after the treatment with phiAGO1.3 they started
to produce progeny, indicating the recovery of reproductive
potential and thereby prompting us to stop the experiment. Taken
together our results demonstrate that the ability of phiAGO1.3
to establish a stable mixed population with its bacterial host
and to exist in equilibrium with the host under in vitro
conditions does not negatively influence the therapeutic potential
of phiAGO1.3.
Nucleotide Sequence Accession Number
The genomic sequence of the S. aureus 80wphwpl WT, control
clone (80wphwpl_v1) has been deposited in the GenBank under
the Accession No. CP034098.
DISCUSSION
Carefully selected obligatorily lytic bacteriophages that efficiently
kill bacterial pathogens may become the option of choice in
the treatment of infections with antibiotic-resistant bacterial
strains. However, safe introduction of a phage to therapy requires
its biology and outcomes of interactions with its host bacteria
in vitro and in vivo to be examined to the widest extent possible.
Here, we show that the polyvalent staphylococcal lytic
podovirus phiAGO1.3 has properties that make it a potential
candidate for therapeutic applications, identify factors that
contribute to its wide strain range, and prove its therapeutic
efficacy in curing a staphylococcal infection of a model nematode,
Caenorhabditis elegans. Additionally, we demonstrate for the first
time for any staphylococcal lytic phage, that phiAGO1.3 and its
host bacteria can co-exist in a stable equilibrium which can be
maintained owing to the presence in such mixed population of
phage-carrier state cells. The ability to form phage-carrier state
cells with its host not only does not cause the lack of efficacy of
phiAGO1.3 as an antistaphylococcal agent in vivo, but also leads
to the emergence of phage-resistant host mutants impaired in
virulence.
The phiAGO1.3 virion morphology, genomic features and
proteome place this phage among typical Rosenblumvirus phages,
which infect S. aureus (Supplementary Table 2; Vybiral et al.,
2003; Kwan et al., 2005; Son et al., 2010; Kraushaar et al.,
2013; Takemura-Uchiyama et al., 2013; Swift and Nelson, 2014;
Wang et al., 2016; Gozdek et al., 2018). The host range of
only some of them has been studied and varied between 50
and 90% of the S. aureus strains tested (Son et al., 2010;
Kraushaar et al., 2013; Takemura-Uchiyama et al., 2013; Wang
et al., 2016). However, none of these host-range tests were
conducted using the phage propagated in a prophage-free host.
Thus, one cannot exclude that the plaques observed with
certain strains could represent plaques of a prophage-derived
temperate phage. To avoid this ambiguity, we determined the
host range of phiAGO1.3 with various representatives of the
genus Staphylococcus and representatives of 14 S. aureus clonal
complexes using a prophage-free host for phage propagation. Of
75 S. aureus strains tested only some human isolates of CC1,
CC59 and CC398, a bovine mastitis isolate of CC97 and isolates
of CC7 were resistant to phiAGO1.3. However, despite the lack
of productive infection of the majority of these resistant strains,
phiAGO1.3 could cause their lysis from without, indicating that
the resistance in not caused by a lack of appropriate phage
receptors.
The ability of phiAGO1.3 to infect representatives of most of
the S. aureus CCs requires bypassing of staphylococcal Type I
R-M systems (Sau1) of different specificities. We show here that
the main strategy of phiAGO1.3 to overcome the action of R-M
systems of Type I and also Type II is the avoidance or sparcity of
DNA sequences recognized by these systems in its genome. This
strategy appears to be common to all Rosenblumvirus phages.
They all lack in their genomes the GGNCC sequences (targets of
Sau96I) and usually lack or only have single copies of sequences
recognized by certain CC-specific variants of Sau1 (data not
shown).
The absence of the recognition sequences for the Sau1 R-M
systems of certain CCs could in principle be used as a predictor
of the strain-range of a phage. Our results indicate that it is often,
but not always, true. Some CC22 and CC15 strains tested were
infected productively by phiAGO1.3 despite the presence of five
recognition sequences for each of the respective Sau1 systems
in the phiAGO1.3 genome. Some phages encode antirestriction
proteins protecting phage DNA from the host Type I R-M
systems (Labrie et al., 2010; Samson et al., 2013; Iyer et al., 2017).
Although phiAGO1.3 does not encode homologs of known
antirestriction proteins, a role of one of its proteins of unassigned
function in antirestriction cannot be excluded (Supplementary
Table 3, Vybiral et al., 2003).
Some of the CC1 and CC59 strains tested were susceptible to
lysis from without but still could not be infected productively
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by phiAGO1.3, despite a lack or the presence of only a single
copy of recognition sequences for the respective Sau1 systems in
the phage DNA (Table 1). A likely reason for this could be the
action of other R-M systems in these strains. Several S. aureus
strains encode two related Type I R-M systems (Waldron and
Lindsay, 2006; McCarthy and Lindsay, 2010; Monk et al., 2012;
Lindsay, 2014) or contain additional R-M system genes on mobile
elements, such as prophages, pathogenicity islands, or SCC-mec
cassettes (Ito et al., 2004; Dempsey et al., 2005; Noto et al.,
2008). Additionally, one cannot exclude a protective activity of
CRISPR-Cas systems or abortive infection systems (Abi) (Chopin
et al., 2005; Labrie et al., 2010), which also have been found
in some strains of S. aureus (Yang et al., 2015; Cao et al.,
2016; Depardieu et al., 2016). The staphylococcal Abi system
involves the serine/threonine kinase Stk2 which is activated by
phage proteins during lytic development and causes cell death
by phosphorylating essential proteins. Stk2 protects the bacteria
from the infection with all siphoviruses tested. Its influence on
the sensitivity to podoviruses has not been studied.
Productive infection as well as lysis from without can
serve as an indicator of successful phage adsorption to a
bacterial cell. Accordingly, phiAGO1.3 could adsorb to all but
three S. aureus strains tested. One of them is RN4220 whose
WTA is modified by the TarM-mediated α-O-GlcNAcylation
(Li et al., 2015). The inability of phiAGO1.3 to adsorb to
RN4220 cells and the high homology of phiAGO1.3 RBP to
the RBPs of subgroup I Rosenblumvirus phages (Supplementary
Table 2) implies the requirement of WTA β-O-GlcNAcylation
for phiAGO1.3 adsorption. What causes the sensitivity of certain
S. hyicus and S. lugdunensis strains to phiAGO1.3 is unclear. We
detected proteins of only partial homology to the S. aureus TarS
(which mediates WTA β-O-GlcNAcylation) among predicted
gene products of both infected strains (data not shown).
The β-O-GlcNAcylation of WTA is essential for the expression
of methicillin-resistance in S. aureus and requires the function of
TarS protein (Brown et al., 2012). This implies that MRSA strains
are likely to adsorb Rosenbslumvirus genus phages of subgroup I.
In support of that, all three strains that did not adsorb phiAGO1.3
in our tests are MSSA (Figure 1).
We show here that under certain conditions the exposure of
S. aureus cells to phiAGO1.3 can lead to the establishment of
a mixed population in which bacteria and bacteriophages are
in an equilibrium, and remain in a stable ratio even following
several serial passages – an equivalent of multiple generations.
This interaction is reminiscent of so called phage carrier state
cultures (PCSCs) (Lwoff, 1953). In the PCSC, phage-resistant
and phage-sensitive cells co-exist in an equilibrium supporting a
continuous growth of the bacterial as well as the phage population
(Lwoff, 1953; Abedon, 2009). The bacteriophage carrier state has
been described for over a dozen of bacteria (Hooton et al., 2016,
and references therein), but as far as we know this is the first
report of such a relation between staphylococci and their lytic
phage.
In PCSCs phage resistance can be determined genetically and
associated with the emergence of phage sensitive cells or it can
be determined by phenotypic traits only. At least two phage-
dependent mechanisms may be responsible for the latter. In the
first case, exemplified by P22 PCSC, proteins that determine
superinfection immunity of some cells in the population are
inherited cytoplasmically by progeny cells despite the loss of P22
resulting from asymmetric cell division (Cenens et al., 2015).
When the phage is removed from the PCSC (e.g., with anti-
phage serum) the proportion of cells resistant to superinfection
decreases with cell divisions and finally they disappear altogether
due to dilution of the immunity factor in the cells. In the second
case, uninfected bacteria are modified by soluble factors released
from the phage-infected bacteria (Abedon, 2009). For instance
lysin released from T7-infected S. dysenteriae cells at phage
release inactivates the phage receptors of uninfected cells and
thus induces a stable equilibrium between infected and non-
infected cells (Li et al., 1961). Its concentration decreases with
the increasing proportion of modified uninfected cells, until a
threshold is reached below which cells recover phage sensitivity
(Abedon, 2009). Some bacteria can modify the display of phage
receptors or the specificity of their Type I or Type II R-M in
the population in a phage-independent manner, e.g., by phase
variation (Abedon, 2009; Seed et al., 2012; Cota et al., 2015;
Anjum et al., 2016; Aidley et al., 2017; De Ste Croix et al., 2017).
The phage population in this case would be maintained solely by
infecting those bacteria in the population that currently display
the receptor or do not restrict a given phage DNA. Phase variation
is also a cause of intra-populational diversity of certain surface
properties in S. aureus. For instance the adhesive properties and
the ability to form biofilm may be diversified among the cells of
a population as a result of reversible insertion/excision of IS256
or the expansion/contraction of a tandem repeat in icaC – a gene
involved in the synthesis of poly-N-acetylglucosamine (PNAG)
which is a major component of the biofilm matrix (Kiem et al.,
2004; Arciola et al., 2015).
The maintenance of PCSCs can be advantageous to bacterial
populations. For instance PCSCs of Campylobacter jejuni
could serve as phage delivery vectors to new target hosts
within pre-colonized chicken, facilitating the acquisition of new
environment for the bacteria and for its phage (Šišáková et al.,
2013). Here, we show that the ability of bacteriophage phiAGO1.3
to be maintained in the form of a phage carrier state population
with its host S. aureus strain in laboratory cultures does not
preclude its ability to cure C. elegans from infection with the
same S. aureus strain. A few reasons for this discrepancy are
possible: (i) the phage carrier state could be limited to certain
conditions only and cannot be maintained in vivo, (ii) limitation
of the bacterial load by phages killing the sensitive fraction of cells
suffices for the natural antimicrobial defense of the nematode
to combat the infection, (iii) the phage carrier state somehow
interferes with the bacterial virulence.
In certain bacterial pathogens phase-variation-dependent
phage resistance phenotypes are associated with changes that
abolish virulence (Seed et al., 2012; Cota et al., 2015). The
maintenance of the subpopulation of phage susceptible cells may
be a temporal cost overweighted by the increased fitness of these
pathogens upon infection of a human or animal. We found
here that the mutation emerging in the population of 80wphwpl
cells infected with phiAGO1.3 and causing the resistance to
phiAGO1.3 leads to the synthesis of a truncated inactive version
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of ArlS protein. ArlS is a part of the two-component ArlR-ArlS
system known to affect several functions associated with S. aureus
virulence and surface properties, either directly or through other
regulatory systems, agr among them (Fournier and Hooper, 2000;
Fournier et al., 2001; Liang et al., 2005; Luong and Lee, 2006).
The ArlRS system is involved in catheter colonization and in
endothelial cell damage by S. aureus (Burgui et al., 2018; Seidl
et al., 2018). It is required for establishing invasive S. aureus
infection and resistance to calprotectin-mediated Mn starvation
in vivo and has been shown to be essential for pathogenesis
in a rabbit model of sepsis and infective endocarditis (Walker
et al., 2013; Radin et al., 2016). Mutations that abolish ArlRS
functioning cause, among other defects, the inability of cells
to agglutinate, decrease protein A expression in certain media,
capsule production and intercellular adhesion, and lead to a
serious deficit in the PNAG production (Luong and Lee, 2006;
Burgui et al., 2018; Villanueva et al., 2018).
Certain virulence factors that are down-regulated in the
ArlRS-deficient mutant, e.g., the Ser-Asp-rich bone fibronectin-
binding proteins SdrC, SdrD, and SdrE (Liang et al., 2005)
require sortase A (SrtA) to be covalently anchored to the cell
wall peptidoglycan (Mazmanian et al., 2001). S. aureus srtA
deletion mutants have been shown to be resistant to infection
with phiAGO1.3-related phages 44AHJD, 66 and 68 (Li et al.,
2015). It seems plausible that the cell surface change that
causes the phiAGO1.3 resistance of arlS mutants concerns
a sortase-dependent protein. One of the Sdr proteins is a
candidate.
A common feature of the srtA deletion mutant studied
by Li et al. (2015) and our arlS mutant is their sensitivity
to a polyvalent Kayvirus phage, K and A5W, respectively.
Phage K requires only the WTA backbone for adsorption,
independently of WTA modifications (Xia et al., 2010, 2011;
Li et al., 2015). Another Kayvirus, φSA012, contains two RBPs
of which one, gp103, binds to α-O-GlcNAc substituted WTA
and the other, gp105, to the WTA backbone (Takeuchi et al.,
2016). Of the two RBPs of A5W (gpORF094 [ACB89087]
and gpORF96 [ACB89089.1) one is identical with a phage
K RBP, while the other is 98% identical to φSA012 gp103,
implying that phage A5W can use both the WTA backbone
and the α-O-GlcNAc substituted WTA for adsorption, unlike
phiAGO1.3. Thus, phiAGO1.3 appears to be not only a good
candidate for a therapeutic use itself but also as a component of
therapeutic phage cocktails with A5W and other Kayvirus genus
phages.
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